Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

07.08.2017

25 Ann Surg Oncol
2 BMC Cancer
1 Breast Cancer
2 Breast Cancer Res
11 Breast Cancer Res Treat
1 Cancer
1 Cancer Chemother Pharmacol
1 Cancer Epidemiol Biomarkers Prev
2 Cancer Res
1 Cell
2 Clin Breast Cancer
1 Eur J Cancer
1 Eur J Surg Oncol
2 Histopathology
3 Int J Oncol
1 J Clin Oncol
1 J Surg Oncol
1 N Engl J Med
1 Nat Rev Clin Oncol
1 NPJ Breast Cancer
3 Oncogene
3 Oncol Rep
4 PLoS One



    Ann Surg Oncol

  1. CAUDLE AS, Bedrosian I, Milton DR, DeSnyder SM, et al
    Use of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surgeons Members.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5958.
    >> Share

  2. SCHUMACHER JR, Taylor LJ, Tucholka JL, Poore S, et al
    Socioeconomic Factors Associated with Post-Mastectomy Immediate Reconstruction in a Contemporary Cohort of Breast Cancer Survivors.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5933.
    >> Share

  3. MILLER ME, Muhsen S, Olcese C, Patil S, et al
    Contralateral Breast Cancer Risk in Women with Ductal Carcinoma In Situ: Is it High Enough to Justify Bilateral Mastectomy?
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5931.
    >> Share

  4. KUERER HM, Vrancken Peeters MTFD, Rea DW, Basik M, et al
    Nonoperative Management for Invasive Breast Cancer After Neoadjuvant Systemic Therapy: Conceptual Basis and Fundamental International Feasibility Clinical Trials.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5926.
    >> Share

  5. MURPHY AE, Hussain L, Ho C, Dunki-Jacobs E, et al
    Preoperative Panel Testing for Hereditary Cancer Syndromes Does Not Significantly Impact Time to Surgery for Newly Diagnosed Breast Cancer Patients Compared with BRCA1/2 Testing.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5957.
    >> Share

  6. WENZ F
    Keynote Address at the American Society of Breast Surgeons 18th Annual Meeting : Current and Future Application of Intraoperative Radiotherapy (IORT) in the Curative and Palliative Treatment of Breast Cancer.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5942.
    >> Share

  7. HESSLER LK, Molitoris JK, Rosenblatt PY, Bellavance EC, et al
    Factors Influencing Management and Outcome in Patients with Occult Breast Cancer with Axillary Lymph Node Involvement: Analysis of the National Cancer Database.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5928.
    >> Share

  8. WELSH JL, Hoskin TL, Day CN, Habermann EB, et al
    Predicting Nodal Positivity in Women 70 Years of Age and Older with Hormone Receptor-Positive Breast Cancer to Aid Incorporation of a Society of Surgical Oncology Choosing Wisely Guideline into Clinical Practice.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5932.
    >> Share

  9. CHAGPAR AB, Hatzis C, Pusztai L, DiGiovanna MP, et al
    Association of LN Evaluation with Survival in Women Aged 70 Years or Older With Clinically Node-Negative Hormone Receptor Positive Breast Cancer.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5936.
    >> Share

  10. PILEWSKIE M, Zabor EC, Mamtani A, Barrio AV, et al
    The Optimal Treatment Plan to Avoid Axillary Lymph Node Dissection in Early-Stage Breast Cancer Patients Differs by Surgical Strategy and Tumor Subtype.
    Ann Surg Oncol. 2017 Jul 31. doi: 10.1245/s10434-017-6016.
    >> Share

  11. O'NEILL AC, Zhong T, Hofer SOP
    Implications of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) for Breast Cancer Reconstruction: An Update for Surgical Oncologists.
    Ann Surg Oncol. 2017 Jul 31. doi: 10.1245/s10434-017-6014.
    >> Share

  12. MCGUIRE A, Lowery AJ, Kell MR, Kerin MJ, et al
    Locoregional Recurrence Following Breast Cancer Surgery in the Trastuzumab Era: A Systematic Review by Subtype.
    Ann Surg Oncol. 2017 Jul 28. doi: 10.1245/s10434-017-6021.
    >> Share

  13. HARRIS CK, Tran HT, Lee K, Mylander C, et al
    Positive Ultrasound-guided Lymph Node Needle Biopsy in Breast Cancer may not Mandate Axillary Lymph Node Dissection.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5935.
    >> Share

  14. SILVERSTEIN MJ, Epstein MS, Lin K, Chen P, et al
    Intraoperative Radiation Using Low-Kilovoltage X-Rays for Early Breast Cancer: A Single Site Trial.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5934.
    >> Share

  15. NGUYEN TT, Hieken TJ, Glazebrook KN, Boughey JC, et al
    Localizing the Clipped Node in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Early Learning Experience and Challenges.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-6023.
    >> Share

  16. MCLAUGHLIN SA, Staley AC, Vicini F, Thiruchelvam P, et al
    Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel : Part 1: Definitions, Assessments, Education, and Future Directions.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5982.
    >> Share

  17. KIM SY, Kawaguchi T, Yan L, Young J, et al
    Clinical Relevance of microRNA Expressions in Breast Cancer Validated Using the Cancer Genome Atlas (TCGA).
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5984.
    >> Share

  18. NGUYEN TT, Hoskin TL, Habermann EB, Cheville AL, et al
    Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5960.
    >> Share

  19. MENDEZ J, Boughey JC
    Changing Dogma and Decreased Collateral Damage in Breast Cancer Care.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5937.
    >> Share

  20. NEWMAN LA
    Breast Cancer Disparities: Socioeconomic Factors versus Biology.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5977.
    >> Share

  21. ROSSO KJ, Tadros AB, Weiss A, Warneke CL, et al
    Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5952.
    >> Share

  22. MCLAUGHLIN SA, DeSnyder SM, Klimberg S, Alatriste M, et al
    Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema, Recommendations from an Expert Panel: Part 2: Preventive and Therapeutic Options.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5964.
    >> Share

  23. ELDER EA, Ferlin A, Vallow LA, Li Z, et al
    The Influence of Breast Density on Preoperative MRI Findings and Outcome in Patients with a Known Diagnosis of Breast Cancer.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5981.
    >> Share

  24. O'LEARY E, Iacoboni D, Holle J, Michalski ST, et al
    Expanded Gene Panel Use for Women With Breast Cancer: Identification and Intervention Beyond Breast Cancer Risk.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5963.
    >> Share

  25. MUSTAFA RE, DeStefano LM, Bahng J, Yoon-Flannery K, et al
    Evaluating the Risk of Upstaging HER2-Positive DCIS to Invasive Breast Cancer.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-5941.
    >> Share


    BMC Cancer

  26. GAUCK D, Keil S, Niggemann B, Zanker KS, et al
    Hybrid clone cells derived from human breast epithelial cells and human breast cancer cells exhibit properties of cancer stem/initiating cells.
    BMC Cancer. 2017;17:515.
    >> Share

  27. WANG L, Widatalla SE, Whalen DS, Ochieng J, et al
    Association of calcium sensing receptor polymorphisms at rs1801725 with circulating calcium in breast cancer patients.
    BMC Cancer. 2017;17:511.
    >> Share


    Breast Cancer

  28. YU Z, Guo X, Jiang Y, Teng L, et al
    Adjuvant endocrine monotherapy for postmenopausal early breast cancer patients with hormone-receptor positive: a systemic review and network meta-analysis.
    Breast Cancer. 2017 Jul 28. doi: 10.1007/s12282-017-0794.
    >> Share


    Breast Cancer Res

  29. JHAVERI K, Wang R, Teplinsky E, Chandarlapaty S, et al
    A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer.
    Breast Cancer Res. 2017;19:89.
    >> Share

  30. KABRAJI S, Sole X, Huang Y, Bango C, et al
    AKT1low quiescent cancer cells persist after neoadjuvant chemotherapy in triple negative breast cancer.
    Breast Cancer Res. 2017;19:88.
    >> Share


    Breast Cancer Res Treat

  31. AHMED M, Jozsa F, Baker R, Rubio IT, et al
    Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients.
    Breast Cancer Res Treat. 2017 Jul 28. doi: 10.1007/s10549-017-4405.
    >> Share

  32. ESPINAL AC, Buas MF, Wang D, Cheng DT, et al
    FOXA1 hypermethylation: link between parity and ER-negative breast cancer in African American women?
    Breast Cancer Res Treat. 2017 Jul 29. doi: 10.1007/s10549-017-4418.
    >> Share

  33. MORENO AYALA MA, Gottardo MF, Imsen M, Asad AS, et al
    Therapeutic blockade of Foxp3 in experimental breast cancer models.
    Breast Cancer Res Treat. 2017 Jul 29. doi: 10.1007/s10549-017-4414.
    >> Share

  34. PETRELLI F, Tomasello G, Barni S, Lonati V, et al
    Clinical and pathological characterization of HER2 mutations in human breast cancer: a systematic review of the literature.
    Breast Cancer Res Treat. 2017 Jul 31. doi: 10.1007/s10549-017-4419.
    >> Share

  35. GEOFFROY M, Kleinclauss A, Grandemange S, Hupont S, et al
    Erratum to: Pro-apoptotic effect of Delta2-TGZ in "claudin-1-low" triple-negative breast cancer cells: involvement of claudin-1.
    Breast Cancer Res Treat. 2017 Jul 31. doi: 10.1007/s10549-017-4402.
    >> Share

  36. KHAN QJ, Kimler BF, Reddy PS, Sharma P, et al
    Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial.
    Breast Cancer Res Treat. 2017 Aug 2. doi: 10.1007/s10549-017-4429.
    >> Share

  37. ZHENG K, Tan JX, Li F, Wei YX, et al
    Relationship between mammographic calcifications and the clinicopathologic characteristics of breast cancer in Western China: a retrospective multi-center study of 7317 female patients.
    Breast Cancer Res Treat. 2017 Aug 2. doi: 10.1007/s10549-017-4406.
    >> Share

  38. ALKNER S, Jensen MB, Rasmussen BB, Bendahl PO, et al
    Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98.
    Breast Cancer Res Treat. 2017 Aug 1. doi: 10.1007/s10549-017-4416.
    >> Share

  39. LUKONG KE, Ogunbolude Y, Kamdem JP
    Breast cancer in Africa: prevalence, treatment options, herbal medicines, and socioeconomic determinants.
    Breast Cancer Res Treat. 2017 Aug 4. doi: 10.1007/s10549-017-4408.
    >> Share

  40. KANG YJ, Han W, Park S, You JY, et al
    Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy.
    Breast Cancer Res Treat. 2017 Aug 1. doi: 10.1007/s10549-017-4423.
    >> Share

  41. FISCHER MJ, Inoue K, Matsuda A, Kroep JR, et al
    Cross-cultural comparison of breast cancer patients' Quality of Life in the Netherlands and Japan.
    Breast Cancer Res Treat. 2017 Jul 31. doi: 10.1007/s10549-017-4417.
    >> Share


    Cancer

  42. PRINTZ C
    Scientists estimate number of U.S. women living with metastatic breast cancer: New data collection and interpretation activities will help advance treatment efforts.
    Cancer. 2017;123:2995-2996.
    >> Share


    Cancer Chemother Pharmacol

  43. PARK WS, Park GJ, Han S, Ban S, et al
    Human microdosing and mice xenograft data of AGM-130 applied to estimate efficacious doses in patients.
    Cancer Chemother Pharmacol. 2017;80:363-369.
    >> Share


    Cancer Epidemiol Biomarkers Prev

  44. BRASKY TM, Krok-Schoen JL, Liu J, Chlebowski RT, et al
    Use of Calcium Channel Blockers and Breast Cancer Risk in the Women's Health Initiative.
    Cancer Epidemiol Biomarkers Prev. 2017;26:1345-1348.
    >> Share


    Cancer Res

  45. CHAN CHT, Munusamy P, Loke SY, Koh GL, et al
    Identification of Novel Breast Cancer Risk Loci.
    Cancer Res. 2017 Aug 3. pii: canres.0992.2017.
    >> Share

  46. REGGIANI F, Labanca V, Mancuso P, Rabascio C, et al
    Adipose progenitor cell secretion of GM-CSF and MMP9 promotes a stromal and immunological microenvironment that supports breast cancer progression.
    Cancer Res. 2017 Jul 28. pii: canres.0914.2017.
    >> Share


    Cell

  47. NABET BY, Qiu Y, Shabason JE, Wu TJ, et al
    Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer.
    Cell. 2017;170:352-366.
    >> Share


    Clin Breast Cancer

  48. DESNYDER SM, Mittendorf EA, Le-Petross C, Krishnamurthy S, et al
    Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer.
    Clin Breast Cancer. 2017 Jul 10. pii: S1526-8209(17)30366.
    >> Share

  49. PARK AY, Seo BK, Han H, Cho KR, et al
    Clinical Value of Real-Time Ultrasonography-MRI Fusion Imaging for Second-Look Examination in Preoperative Breast Cancer Patients: Additional Lesion Detection and Treatment Planning.
    Clin Breast Cancer. 2017 Jul 14. pii: S1526-8209(17)30167.
    >> Share


    Eur J Cancer

  50. KUMMEL S, Paepke S, Huober J, Schem C, et al
    Randomised, open-label, phase II study comparing the efficacy and the safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE).
    Eur J Cancer. 2017;84:1-8.
    >> Share


    Eur J Surg Oncol

  51. LIAO GS, Dai MS, Hsu HM, Chu CH, et al
    Survival outcome of weak estrogen/progesterone receptor expression in HER2 negative breast cancer is similar to triple negative breast cancer.
    Eur J Surg Oncol. 2017 Jul 19. pii: S0748-7983(17)30585.
    >> Share


    Histopathology

  52. EL ANSARI R, McIntyre A, Craze ML, Ellis IO, et al
    Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations.
    Histopathology. 2017 Aug 3. doi: 10.1111/his.13334.
    >> Share

  53. QAISER T, Mukherjee A, Reddy Pb C, Munugoti SD, et al
    Her2 Challenge Contest: A Detailed Assessment of Automated Her2 Scoring Algorithms in Whole Slide Images of Breast Cancer Tissues.
    Histopathology. 2017 Aug 3. doi: 10.1111/his.13333.
    >> Share


    Int J Oncol


  54. [Corrigendum] Transcriptome sequencing of human breast cancer reveals aberrant intronic transcription in amplicons and dysregulation of alternative splicing with major therapeutic implications.
    Int J Oncol. 2017;51:997-0.
    >> Share

  55. D'ANGELO S, Martino E, Ilisso CP, Bagarolo ML, et al
    Pro-oxidant and pro-apoptotic activity of polyphenol extract from Annurca apple and its underlying mechanisms in human breast cancer cells.
    Int J Oncol. 2017;51:939-948.
    >> Share

  56. OBAYASHI S, Horiguchi J, Higuchi T, Katayama A, et al
    Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients.
    Int J Oncol. 2017;51:781-790.
    >> Share


    J Clin Oncol

  57. SJOSTROM M, Lundstedt D, Hartman L, Holmberg E, et al
    Response to Radiotherapy After Breast-Conserving Surgery in Different Breast Cancer Subtypes in the Swedish Breast Cancer Group 91 Radiotherapy Randomized Clinical Trial.
    J Clin Oncol. 2017 Jul 31:JCO2017727263. doi: 10.1200/JCO.2017.72.7263.
    >> Share


    J Surg Oncol

  58. YOSHIDA A, Hayashi N, Suzuki K, Takimoto M, et al
    Change in HER2 status after neoadjuvant chemotherapy and the prognostic impact in patients with primary breast cancer.
    J Surg Oncol. 2017 Aug 2. doi: 10.1002/jso.24762.
    >> Share


    N Engl J Med

  59. HAYMART MR, Miller DC, Hawley ST
    Active Surveillance for Low-Risk Cancers - A Viable Solution to Overtreatment?
    N Engl J Med. 2017;377:203-206.
    >> Share


    Nat Rev Clin Oncol

  60. GINGRAS I, Gebhart G, de Azambuja E, Piccart-Gebhart M, et al
    HER2-positive breast cancer is lost in translation: time for patient-centered research.
    Nat Rev Clin Oncol. 2017 Aug 1. doi: 10.1038/nrclinonc.2017.
    >> Share


    NPJ Breast Cancer

  61. ZUJEWSKI JA, Rubinstein L
    CREATE-X a role for capecitabine in early-stage breast cancer: an analysis of available data.
    NPJ Breast Cancer. 2017;3:27.
    >> Share


    Oncogene

  62. GALLAGHER EJ, Zelenko Z, Neel BA, Antoniou IM, et al
    Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia.
    Oncogene. 2017 Jul 31. doi: 10.1038/onc.2017.
    >> Share

  63. PETERS AA, Jamaludin SYN, Yapa KTDS, Chalmers S, et al
    Oncosis and apoptosis induction by activation of an overexpressed ion channel in breast cancer cells.
    Oncogene. 2017 Jul 31. doi: 10.1038/onc.2017.
    >> Share

  64. HEILMANN K, Toth R, Bossmann C, Klimo K, et al
    Genome-wide screen for differentially methylated long noncoding RNAs identifies Esrp2 and lncRNA Esrp2-as regulated by enhancer DNA methylation with prognostic relevance for human breast cancer.
    Oncogene. 2017 Jul 31. doi: 10.1038/onc.2017.
    >> Share


    Oncol Rep

  65. ZHAO J, Zhi Z, Wang C, Xing H, et al
    Exogenous lipids promote the growth of breast cancer cells via CD36.
    Oncol Rep. 2017 Aug 1. doi: 10.3892/or.2017.5864.
    >> Share

  66. YOU D, Jung SP, Jeong Y, Bae SY, et al
    Wild-type p53 controls the level of fibronectin expression in breast cancer cells.
    Oncol Rep. 2017 Jul 31. doi: 10.3892/or.2017.5860.
    >> Share

  67. CHU S, Liu G, Xia P, Chen G, et al
    miR-93 and PTEN: Key regulators of doxorubicin-resistance and EMT in breast cancer.
    Oncol Rep. 2017 Jul 31. doi: 10.3892/or.2017.5859.
    >> Share


    PLoS One

  68. ETTI IC, Abdullah R, Kadir A, Hashim NM, et al
    The molecular mechanism of the anticancer effect of Artonin E in MDA-MB 231 triple negative breast cancer cells.
    PLoS One. 2017;12:e0182357.
    >> Share

  69. SIM SH, Bae CD, Kwon Y, Hwang HL, et al
    CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer.
    PLoS One. 2017;12:e0182107.
    >> Share

  70. MATOSSIAN MD, Elliott S, Hoang VT, Burks HE, et al
    Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes.
    PLoS One. 2017;12:e0177802.
    >> Share

  71. SADIGHI S, Zokaasadi M, Kasaeian A, Maghsudi S, et al
    The effect of immunohistochemically detected p53 accumulation in prognosis of breast cancer; A retrospective survey of outcome.
    PLoS One. 2017;12:e0182444.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016